MA47110A - Polythérapie avec des composés de ss-lactame substitués par amidine et des inhibiteurs de ss-lactamase pour des infections par des souches bactériennes résistantes aux antibiotiques - Google Patents
Polythérapie avec des composés de ss-lactame substitués par amidine et des inhibiteurs de ss-lactamase pour des infections par des souches bactériennes résistantes aux antibiotiquesInfo
- Publication number
- MA47110A MA47110A MA047110A MA47110A MA47110A MA 47110 A MA47110 A MA 47110A MA 047110 A MA047110 A MA 047110A MA 47110 A MA47110 A MA 47110A MA 47110 A MA47110 A MA 47110A
- Authority
- MA
- Morocco
- Prior art keywords
- polytherapy
- amidine
- infections
- bacterial strains
- antibiotic resistant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16205800 | 2016-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47110A true MA47110A (fr) | 2019-10-30 |
Family
ID=57583080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047110A MA47110A (fr) | 2016-12-21 | 2017-12-21 | Polythérapie avec des composés de ss-lactame substitués par amidine et des inhibiteurs de ss-lactamase pour des infections par des souches bactériennes résistantes aux antibiotiques |
Country Status (13)
Country | Link |
---|---|
US (1) | US20200093814A1 (fr) |
EP (1) | EP3558987A1 (fr) |
JP (1) | JP2020502210A (fr) |
KR (1) | KR20190092566A (fr) |
CN (1) | CN110312715A (fr) |
AU (1) | AU2017339587A1 (fr) |
BR (1) | BR112019012994A2 (fr) |
CA (1) | CA3047634A1 (fr) |
EA (1) | EA201991523A1 (fr) |
IL (1) | IL267525A (fr) |
MA (1) | MA47110A (fr) |
MX (1) | MX2019007613A (fr) |
WO (1) | WO2018065636A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111511737B (zh) | 2018-01-29 | 2022-10-18 | 南京明德新药研发有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
TW202024068A (zh) * | 2018-11-13 | 2020-07-01 | 大陸商南京聖和藥業股份有限公司 | 單環內醯胺化合物及其應用 |
CN109762841B (zh) * | 2018-11-19 | 2021-03-02 | 厦门联合安金生物工程有限公司 | BPI-Fc融合蛋白及其用途 |
EP3901150A4 (fr) * | 2018-12-18 | 2022-09-07 | Medshine Discovery Inc. | Application d'un composé beta-lactame monocyclique en pharmacie |
CN111303144B (zh) * | 2019-12-13 | 2020-11-27 | 苏州信诺维医药科技有限公司 | 一种治疗细菌感染的化合物 |
CN114828850B (zh) * | 2019-12-19 | 2024-08-13 | 深圳嘉科生物科技有限公司 | 化合物在制药中的应用 |
CN111592536B (zh) * | 2020-06-04 | 2023-11-03 | 宁夏农林科学院农业资源与环境研究所(宁夏土壤与植物营养重点实验室) | 单环β-内酰胺化合物及其制备方法和应用 |
EP4165039B1 (fr) * | 2020-07-16 | 2024-08-21 | Ningxia Academy of Agriculture and Forestry Sciences | Nouveaux composés monobactam, leur préparation et leur utilisation en tant qu'agents antibactériens |
US20230150996A1 (en) * | 2020-08-06 | 2023-05-18 | Ningxia Academy Of Agriculture And Forestry Sciences | B-lactam compounds, their preparation and use as antibacterial agents |
CN113350337B (zh) * | 2021-07-07 | 2022-07-19 | 中国海洋大学 | 一种用于抑制多药耐药细菌的克拉维酸和氨曲南的组合物及其应用 |
CN113975396B (zh) * | 2021-11-09 | 2022-11-29 | 中国医学科学院医药生物技术研究所 | 包含β-内酰胺类化合物的药物组合物及其用途 |
EP4431113A1 (fr) * | 2021-11-09 | 2024-09-18 | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | COMPOSITION PHARMACEUTIQUE CONTENANT UN COMPOSÉ DE ß-LACTAME ET SON UTILISATION |
WO2023091438A1 (fr) * | 2021-11-18 | 2023-05-25 | Merck Sharp & Dohme Llc | Antibiotiques monobactams de chromane amidine |
CN116115664B (zh) * | 2023-02-14 | 2024-08-23 | 河南省农业科学院畜牧兽医研究所 | 一种用于抑制同时携带多种新德里金属-β-内酰胺酶的大肠杆菌抗菌化合物及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112968A (en) | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
CA2024282A1 (fr) | 1989-09-21 | 1991-03-22 | Peter H. Ermann | Derives hydrazide heterocycliques de beta-lactam monocyclique antibiotique |
ZA918014B (en) | 1990-11-05 | 1992-07-29 | Squibb & Sons Inc | Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
US5250691A (en) | 1991-09-09 | 1993-10-05 | E. R. Squibb & Sons, Inc. | Heteroaryl derivatives of monocyclic beta-lactam antibiotics |
IL154593A0 (en) | 2000-09-14 | 2003-09-17 | Pantherix Ltd | 3-(heteroaryl acetamido)-2-oxoazetidine-1-sulfonic acid derivatives as antibacterial agents |
ATE529111T1 (de) | 2005-12-07 | 2011-11-15 | Basilea Pharmaceutica Ag | Nützliche monobactam-antibiotika |
CN101641095B (zh) | 2007-03-23 | 2012-10-31 | 巴斯利尔药物股份公司 | 用于治疗细菌感染的组合药物 |
CA2744756C (fr) | 2008-12-19 | 2013-05-28 | Pfizer Inc. | Monocarbames et leur utilisation comme agent antibacterien |
UY34585A (es) * | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
WO2013110633A1 (fr) * | 2012-01-24 | 2013-08-01 | Oerlikon Textile Gmbh & Co. Kg | Dispositif permettant d'humidifier plusieurs fils |
-
2017
- 2017-12-21 EP EP17832956.1A patent/EP3558987A1/fr not_active Withdrawn
- 2017-12-21 US US16/471,677 patent/US20200093814A1/en not_active Abandoned
- 2017-12-21 KR KR1020197020830A patent/KR20190092566A/ko unknown
- 2017-12-21 EA EA201991523A patent/EA201991523A1/ru unknown
- 2017-12-21 MX MX2019007613A patent/MX2019007613A/es unknown
- 2017-12-21 JP JP2019533438A patent/JP2020502210A/ja active Pending
- 2017-12-21 AU AU2017339587A patent/AU2017339587A1/en not_active Abandoned
- 2017-12-21 MA MA047110A patent/MA47110A/fr unknown
- 2017-12-21 CN CN201780079780.5A patent/CN110312715A/zh active Pending
- 2017-12-21 WO PCT/EP2017/084064 patent/WO2018065636A1/fr unknown
- 2017-12-21 CA CA3047634A patent/CA3047634A1/fr not_active Abandoned
- 2017-12-21 BR BR112019012994A patent/BR112019012994A2/pt not_active Application Discontinuation
-
2019
- 2019-06-19 IL IL267525A patent/IL267525A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN110312715A (zh) | 2019-10-08 |
MX2019007613A (es) | 2019-09-04 |
IL267525A (en) | 2019-08-29 |
BR112019012994A2 (pt) | 2019-12-03 |
JP2020502210A (ja) | 2020-01-23 |
WO2018065636A1 (fr) | 2018-04-12 |
AU2017339587A1 (en) | 2019-07-04 |
KR20190092566A (ko) | 2019-08-07 |
EA201991523A1 (ru) | 2019-11-29 |
CA3047634A1 (fr) | 2018-04-12 |
EP3558987A1 (fr) | 2019-10-30 |
US20200093814A1 (en) | 2020-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA47110A (fr) | Polythérapie avec des composés de ss-lactame substitués par amidine et des inhibiteurs de ss-lactamase pour des infections par des souches bactériennes résistantes aux antibiotiques | |
HRP20190501T1 (hr) | Monobaktam organski spojevi za liječenje bakterijskih infekcija | |
GB2609346B (en) | Treating & preventing microbial infections | |
BR112018005698A2 (pt) | Assistente de gravação de linha de bit negativa adaptável | |
MA46242A (fr) | Composés inhibiteurs de bêta-lactamase | |
DK3743086T3 (da) | Sammensætningner omfattende bakteriestammer | |
EP3220741A4 (fr) | Composition et kits pour l'inhibition d'une infection microbienne pathogène et leurs méthodes d'utilisation | |
CL2016002918A1 (es) | Compuestos derivados de quinazolina-4(3h)-ona-n-hidroxi-2-metil-2-metilsulfonil-butanamida; composicion farmaceutica; actividad antibacteriana gram-negativo. | |
DK3385377T3 (da) | Bakteriemannanaser | |
GB201900832D0 (en) | Organic field-effect transistors | |
EP3428299A4 (fr) | Tuyau en acier électrosoudé pour tuyau de canalisation | |
HK1254239A1 (zh) | 有效對抗多藥耐藥細菌的新的氨基糖苷抗生素 | |
EP3519429A4 (fr) | Inhibiteurs bactériens | |
GB201909003D0 (en) | Anonymization | |
IL283961A (en) | organic compound | |
MA43791A (fr) | Composés de carbapénème | |
EP3324992A4 (fr) | Agents inverses pour inhibiteurs de fxia | |
GB201806052D0 (en) | Detection of bacterial infections | |
DK3647404T3 (da) | Bioreaktor | |
HUE064328T2 (hu) | Immunprofilaxis visszatérõ bakteriális fertõzésekre | |
ES1219853Y (es) | Instalacion de cultivo | |
GB201819570D0 (en) | Multiple-gate transistor | |
GB201804781D0 (en) | Treating & preventing preventing microbial infections | |
UA38016S (uk) | Ключ трубний | |
GB201721022D0 (en) | Detection of bacterial infections |